Bacterial Infections Post Liver Transplantation; One Year Experience

Document Type : Original Article


1 Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

2 Shiraz Transplant Center, Abu-Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

3 Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran



In adults with acute and chronic end-stage liver disease, liver transplantation (LT) is the only treatment option for these patients. On the other hand, one of the substantial causes of death in these patients is bacterial infection after transplantation, which should be considered as well as appropriate antibacterial treatment. For this reason, this study was designed to provide a multi-faceted review of different types of infections after transplantation and their treatment options during one year of experience in the largest LT center for adult patients in Iran. In this retrospective cohort study, records from all individuals over 18 years of age candidates for liver transplantation in Abu-Ali Sina hospital, Shiraz, Fars, Iran from 2018   March to 2019 March , were assessed. Demographic, laboratory, and clinical data were extracted in addition to the antimicrobial therapy. In this study, 412 patients included. 15.77% of patients were infected after transplantation, of which 61.17% of the isolated pathogens were gram-negative and 38.83% were gram-positive. The most common isolated gram-positive and gram-negative microorganisms include staphylococci (27.69%) and Klebsiella (27.69%), respectively. Urinary tract infection was the most common type of infection after transplantation in adult liver transplant recipients, and length of stay in ICU, length of hospital stay, length of mechanical ventilation are among the risk factors affecting bacterial infection after LT.


Mojtaba Shafiekhani (Google Scholar)


1.    Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med. 2019 Jan;33(1):24-36. doi: 10.1177/0269216318807051. Epub 2018 Oct 22. PMID: 30345878; PMCID: PMC6291907.
2.    Mallik M, Singhai A, Khadanga S, Ingle V. The Significant Morbidity and Mortality Indicators in Patients of Cirrhosis. Cureus. 2022 Jan 14;14(1):e21226. doi: 10.7759/cureus.21226. PMID: 35174029; PMCID: PMC8841014.
3.    Babb RR. Chronic liver disease. The scope of causes and treatments. Postgrad Med. 1992 May 15;91(7):89-96. doi: 10.1080/00325481.1992.11701346. PMID: 1589371.
4.    Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27. PMID: 32043613.
5.    O'Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol. 2014 Mar;60(3):663-70. doi: 10.1016/j.jhep.2013.10.024. Epub 2013 Nov 6. PMID: 24211740.
6.    Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis. 1995 Nov;21(5):1077-89; quiz 1090-1. doi: 10.1093/clinids/21.5.1077. PMID: 8589125.
7.    Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. 2014 May 28;20(20):6211-20. doi: 10.3748/wjg.v20.i20.6211. PMID: 24876741; PMCID: PMC4033458.
8.    Hernandez Mdel P, Martin P, Simkins J. Infectious Complications After Liver Transplantation. Gastroenterol Hepatol (N Y). 2015 Nov;11(11):741-53. PMID: 27134589; PMCID: PMC4849501.
9.    van Hoek B, de Rooij BJ, Verspaget HW. Risk factors for infection after liver transplantation. Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):61-72. doi: 10.1016/j.bpg.2012.01.004. PMID: 22482526.
10.    Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation--part I. Liver Transpl. 2005 Dec;11(12):1452-9. doi: 10.1002/lt.20624. PMID: 16315310.
11.    Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar;45(3):797-805. doi: 10.1002/hep.21563. PMID: 17326206.
12.    World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053. PMID: 24141714.
13.    Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun;36(5):309-32. doi: 10.1016/j.ajic.2008.03.002. Erratum in: Am J Infect Control. 2008 Nov;36(9):655. PMID: 18538699.
14.    Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27. PMID: 21793988.
15.    Kawecki D, Pacholczyk M, Lagiewska B, Sawicka-Grzelak A, Durlik M, Mlynarczyk G, et al. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc. 2014 Oct;46(8):2777-81. doi: 10.1016/j.transproceed.2014.08.031. PMID: 25380916.
16.    Li C, Wen TF, Mi K, Wang C, Yan LN, Li B. Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol. 2012 Apr 28;18(16):1975-80. doi: 10.3748/wjg.v18.i16.1975. PMID: 22563180; PMCID: PMC3337575.
17.    Jafarpour Z, Pouladfar G, Malek Hosseini SA, Firoozifar M, Jafari P. Bacterial infections in the early period after liver transplantation in adults: A prospective single-center cohort study. Microbiol Immunol. 2020 Jun;64(6):407-415. doi: 10.1111/1348-0421.12785. Epub 2020 May 18. PMID: 32112581.
18.    Righi E. Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions. World J Gastroenterol. 2018 Oct 14;24(38):4311-4329. doi: 10.3748/wjg.v24.i38.4311. PMID: 30344417; PMCID: PMC6189843.
19.    Sun HY, Cacciarelli TV, Singh N. Identifying a targeted population at high risk for infections after liver transplantation in the MELD era. Clin Transplant. 2011 May-Jun;25(3):420-5. doi: 10.1111/j.1399-0012.2010.01262.x. Epub 2010 May 10. PMID: 20482564.
20.    Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, Davenport A, Gropper M. Critical care issues in patients after liver transplantation. Liver Transpl. 2011 May;17(5):511-27. doi: 10.1002/lt.22291. PMID: 21384524.
21.    Freire MP, Oshiro IC, Pierrotti LC, Bonazzi PR, de Oliveira LM, Song AT, et al. Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes. Transplantation. 2017 Apr;101(4):811-820. doi: 10.1097/TP.0000000000001620. PMID: 28009779; PMCID: PMC7228606.
22.    Otan E, Aydin C, Usta S, Kutluturk K, Kayaalp C, Yilmaz S. Acinetobacter infection in a liver transplantation intensive care unit. Transplant Proc. 2013 Apr;45(3):998-1000. doi: 10.1016/j.transproceed.2013.02.077. PMID: 23622607.
23.    So M, Walti L. Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients. Curr Infect Dis Rep. 2022;24(5):63-75. doi: 10.1007/s11908-022-00778-1. Epub 2022 Apr 30. PMID: 35535263; PMCID: PMC9055217.
24.    Radunz S, Juntermanns B, Kaiser GM, Treckmann J, Mathe Z, Paul A, et al. Efficacy and safety of linezolid in liver transplant patients. Transpl Infect Dis. 2011 Aug;13(4):353-8. doi: 10.1111/j.1399-3062.2011.00617.x. Epub 2011 Feb 28. PMID: 21355969.
25.    Sganga G, Bianco G, Fiori B, Nure E, Spanu T, Lirosi MC, et al. Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011. Transplant Proc. 2013 Sep;45(7):2718-21. doi: 10.1016/j.transproceed.2013.08.010. PMID: 24034031.
26.    Liu T, Zhang Y, Wan Q. Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality. Infect Drug Resist. 2018 May 3;11:647-658. doi: 10.2147/IDR.S161180. PMID: 29765236; PMCID: PMC5939879.
27.    Calfee DP, Salgado CD, Milstone AM, Harris AD, Kuhar DT, Moody J, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014 Jul;35(7):772-96. doi: 10.1086/676534. PMID: 24915205.
28.    Takatsuki M, Eguchi S, Yamanouchi K, Hidaka M, Soyama A, Miyazaki K, et al. The outcomes of methicillin-resistant Staphylococcus aureus infection after living donor liver transplantation in a Japanese center. J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):839-43. doi: 10.1007/s00534-010-0273-5. Epub 2010 Apr 8. PMID: 20734207.
29.    Banach DB, Peaper DR, Fortune BE, Emre S, Dembry LM. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients. Clin Transplant. 2016 Mar;30(3):306-11. doi: 10.1111/ctr.12690. Epub 2016 Feb 9. PMID: 26780305.
30.    Garzoni C, Vergidis P; AST Infectious Diseases Community of Practice. Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation. Am J Transplant. 2013 Mar;13 Suppl 4:50-8. doi: 10.1111/ajt.12098. PMID: 23464998.
31.    Nellore A, Huprikar S; AST ID Community of Practice. Vancomycin-resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019 Sep;33(9):e13549. doi: 10.1111/ctr.13549. Epub 2019 May 7. PMID: 30913322.
32.    Shafiekhani M, Shabani-Borujeni M, Karimian A, MomeniTabar MJ, Zare Z, Arabsheybani S, et al. Antibiotic stewardship implementation at the largest solid organ transplantation center in Asia: a retrospective cohort study. BMC Surg. 2023 Apr 11;23(1):81. doi: 10.1186/s12893-023-01991-y. PMID: 37041483; PMCID: PMC10091536.